Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant in QL Block for C-Section
NCT04748224Completed
- Sponsor
- Cairo University
- Start
- Feb 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Total amount of morphine consumption at 24 hours. Started Feb 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04748224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04748224.